Codexis Aandeel

Codexis EBITDA

De EBITDA (Winst voor rente, belastingen, afschrijvingen en amortisaties) van Codexis (CDXS) per 15 aug 2026 bedraagt -41,74 Miljoen USD. In het voorgaande jaar bedroeg EBITDA (Winst voor rente, belastingen, afschrijvingen en amortisaties) -53,67 Miljoen USD — een verandering van -22,24% (hoger).

EBITDA

-41,74 MiljoenUSD

YoY

-22,24%

Laatst bijgewerkt:

EBITDA (Winst voor rente, belastingen, afschrijvingen en amortisaties) van Codexis is 2026 -41,74 Miljoen USD. EBITDA (Winst voor rente, belastingen, afschrijvingen en amortisaties) van Codexis was 2025 -53,67 Miljoen USD. Het is daarmee -22,24% hoger lager dan het jaar ervoor.
Access this data via the Eulerpool API

Codexis Aandelenanalyse

Wat doet Codexis? Codexis Inc. is an American biotechnology company that specializes in developing innovative biological solutions for a variety of industries. The company was founded in 2002 and is headquartered in Redwood City, California. Business Model: Codexis is service-oriented and provides customized enzyme solutions for companies looking to improve their products through sustainable processes. The company has developed a unique platform called Rational Protein Engineering, which allows for the development of specific enzymes for various industries. Customers benefit from enzyme optimization expertise and know-how. Divisions: Codexis operates in the fields of life sciences, materials science, agrochemicals, and biofuels. 1. Life Sciences: Codexis specializes in the production of enzymes and biocatalysts for the pharmaceutical industry in the life sciences division. The goal is to provide a faster and more efficient manufacturing process for pharmaceutical active ingredients. The company has successfully developed active ingredients for antibodies, lipids, uric acid, and antivirals. 2. Materials Science: In the materials science division, Codexis specializes in the production of enzymes for materials such as dyes, polymers, and cosmetic products. Codexis ensures that these products are efficiently manufactured without the use of environmentally harmful chemicals. 3. Agrochemicals: Codexis offers customized enzyme solutions to agrochemical manufacturers that reduce the use of chemicals and benefit the environment. These enzymes help in the production of pesticides and other agrochemicals. 4. Biofuels: In the biofuels division, Codexis specializes in the production of enzymes for processing corn, harvested plants, or waste products. These enzymes help enable cost-effective biofuel production. Products: Codexis has developed a wide range of products tailored to the needs of various industries. Some of the products recently introduced to the market by Codexis include: 1. CodeEvolver: CodeEvolver is a platform that allows biotechnology companies to quickly create customized enzyme solutions for their specific needs. The process is fully automated and results in a significant reduction in development time and costs. 2. Codex® screening panels: Codexis offers various screening panels that allow customers to quickly and efficiently select the enzymes best suited for their purposes. The panels are suitable for industries including pharmaceuticals, chemicals, and plant protection. 3. Codex® enzymes: Codexis offers a wide range of enzymes specifically designed for different industry needs. This includes enzymes for the production of biofuels, pesticides, cosmetic products, and pharmaceuticals. Overall, Codexis Inc. has demonstrated its ability to deepen the understanding of biocatalysts and introduce innovative biological processes in a variety of industries through its unique Rational Protein Engineering platform. Codexis is een van de meest populaire bedrijven op Eulerpool.

Veelgestelde vragen over het aandeel Codexis

EBITDA (Winst voor rente, belastingen, afschrijvingen en amortisaties) van Codexis bedraagt -41,74 Miljoen USD in 2026.

EBITDA (Winst voor rente, belastingen, afschrijvingen en amortisaties) van Codexis is veranderd van -53,67 Miljoen USD naar -41,74 Miljoen USD, wat een verandering van -22,24% vertegenwoordigt. De waarde is hoger dan het vorige jaar.

Op Eulerpool vindt u de volledige historische ontwikkeling van EBITDA (Winst voor rente, belastingen, afschrijvingen en amortisaties) Codexis sinds 2006 – met jaarlijkse waarden, grafieken en gedetailleerde analyse.

EBITDA meet de operationele prestaties vóór de impact van de financiële structuur, de belastingomgeving en niet-kasmatige afschrijvingskosten.

EBITDA = EBIT + Afschrijvingen en amortisaties

USD van EBITDA (Winst voor rente, belastingen, afschrijvingen en amortisaties) is een belangrijke factor voor beleggers. Veranderingen in deze maatstaf kunnen sterke signalen geven voor toekomstige koersontwikkelingen.

Access this data via the Eulerpool API

Winst-en-verliesrekening — Codexis

Alle kengetallen — Codexis